Our study showed that in the group of mucinous CRC, a higher cytoplasmic (aberrant) expression of E-cadherin coincided with later tumor stage (28.2% vs. 5.7% stage IV), which also correlates with previous research [24]. The gene discussed is CDH1; the disease is colorectal carcinoma.